Compare BRTX & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRTX | DTSS |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 9.0M |
| IPO Year | N/A | N/A |
| Metric | BRTX | DTSS |
|---|---|---|
| Price | $0.26 | $1.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 827.5K | 131.5K |
| Earning Date | 03-26-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $383,400.00 | ★ $64,349,277.00 |
| Revenue This Year | $112.14 | N/A |
| Revenue Next Year | $139.81 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 1.70 | ★ 68.56 |
| 52 Week Low | $0.22 | $0.64 |
| 52 Week High | $2.50 | $2.89 |
| Indicator | BRTX | DTSS |
|---|---|---|
| Relative Strength Index (RSI) | 11.42 | 48.02 |
| Support Level | $0.22 | $0.97 |
| Resistance Level | $1.13 | $1.15 |
| Average True Range (ATR) | 0.09 | 0.15 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 3.22 | 23.28 |
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).